URIS® addresses multiple problems at the same time
URIS® technology provides the best possible quality of life for patients requiring neuromodulation treatment. In addition, it is a more cost-effective option compared to other treatment methods for urge and mixed incontinence, a problem that costs billions of crowns annually.
URIS® is an opportunity to save hundreds of millions of crowns annually in the treatment of urge and mixed incontinence and other diseases treatable through neuromodulation. Additionally, our technology will reduce the ecological footprint currently associated with the treatment of OAB.
OAB SYNDROME AFFECTS MORE THAN 500 MILLION PEOPLE WORLDWIDE
Benefits associated with URIS® reimbursement
| • | By 2050, the number of individuals over the age of 60 will double, which will greatly increase the need for incontinence care. Our technology can reduce the overall associated cost by 5%. |
| • | Increased quality of life for patients with chronic conditions – estimated at 5,810 QALYs annually. |
| • | Reduction in health insurance costs associated with hospital fees as URIS® technology can be used from the comfort of ones’ home. |
| • | Reduced carbon footprint associated with production and reduced waste associated with hygiene materials. |
5% COST SAVINGS IN THE TREATMENT OF INCONTINENT PATIENTS WITH URIS® TECHNOLOGY
Giving people back their quality of life
Read more about how our technology has already helped to improve quality of life for our patients with an overactive bladder disease. Want to know what their life is like after stimulation, what the URIS® treatment itself has brought to them, or the results of our recent clinical trials?
